Bladder Cancer
French AFU Cancer Committee Guidelines - Update 2022-2024: Non-muscle-invasive bladder cancer (NMIBC).
November 22, 2022
Impact of Finasteride on Survival in Bladder Cancer: A Retrospective Multi-institutional Database Analysis.
November 22, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: Muscle-Invasive Bladder Cancer (MIBC).
November 22, 2022
The Efficacy of Chemoradiotherapy for Organ Preservation in Patients with Localized Bladder Cancer - Expert Commentary
November 21, 2022
Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality Therapy.
November 21, 2022
A Phase II Open-label Randomized Controlled Trial of Adjuvant Chemohyperthermia in Patients with Bladder Cancer - Expert Commentary
November 18, 2022
Uretero-enteric Strictures After Robot Assisted Radical Cystectomy: Prevalence and Management Over Two Decades.
November 18, 2022
Reduced IQGAP2 Promotes Bladder Cancer through Regulation of MAPK/ERK Pathway and Cytokines.
November 17, 2022
Immune Response Mediates the Antitumor Activity of EZH2 Inhibition in Bladder Cancer - Expert Commentary
November 16, 2022
Systematic review on oncologic outcomes on adjuvant endovesical treatment for non-muscle invasive bladder cancer in patients with solid organ transplant.
November 16, 2022
Association Between T Cell Exhaustion, Urinary Tumor DNA Levels, and BCG Failure in Bladder Cancer - Expert Commentary
November 15, 2022
Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based Therapy.
November 15, 2022